EP0566266A1 - - Google Patents

Info

Publication number
EP0566266A1
EP0566266A1 EP0566266A1 EP 0566266 A1 EP0566266 A1 EP 0566266A1 EP 0566266 A1 EP0566266 A1 EP 0566266A1
Authority
EP
European Patent Office
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number

Links

Family

ID=

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006012422A1 (en) 2004-07-20 2006-02-02 Osi Pharmaceuticals, Inc. Imidazopyrazine as tyrosine kinase inhibitors
WO2007064993A2 (en) 2005-12-02 2007-06-07 Osi Pharmaceuticals, Inc. Bicyclic protein kinase inhibitors
WO2011029001A1 (en) 2009-09-03 2011-03-10 Allergan, Inc. Compounds as tyrosine kinase modulators
EP2308879A1 (en) 2004-04-02 2011-04-13 OSI Pharmaceuticals, Inc. 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors
WO2011159726A2 (en) 2010-06-14 2011-12-22 The Scripps Research Institute Reprogramming of cells to a new fate
EP2476667A2 (en) 2003-02-26 2012-07-18 Sugen, Inc. Aminoheteroaryl compounds as protein kinase inhibitors
WO2013062843A1 (en) 2011-10-20 2013-05-02 Allergan, Inc. Pyridine- sulfoximines as tyrosine kinase inhibitors
US9340555B2 (en) 2009-09-03 2016-05-17 Allergan, Inc. Compounds as tyrosine kinase modulators

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2476667A2 (en) 2003-02-26 2012-07-18 Sugen, Inc. Aminoheteroaryl compounds as protein kinase inhibitors
EP2308879A1 (en) 2004-04-02 2011-04-13 OSI Pharmaceuticals, Inc. 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors
WO2006012422A1 (en) 2004-07-20 2006-02-02 Osi Pharmaceuticals, Inc. Imidazopyrazine as tyrosine kinase inhibitors
WO2007064993A2 (en) 2005-12-02 2007-06-07 Osi Pharmaceuticals, Inc. Bicyclic protein kinase inhibitors
WO2011029001A1 (en) 2009-09-03 2011-03-10 Allergan, Inc. Compounds as tyrosine kinase modulators
US9340555B2 (en) 2009-09-03 2016-05-17 Allergan, Inc. Compounds as tyrosine kinase modulators
WO2011159726A2 (en) 2010-06-14 2011-12-22 The Scripps Research Institute Reprogramming of cells to a new fate
WO2013062843A1 (en) 2011-10-20 2013-05-02 Allergan, Inc. Pyridine- sulfoximines as tyrosine kinase inhibitors